Cardiac Troponin for the Diagnosis and Risk-Stratification of Myocardial Injury in COVID-19

Diagnosis and Risk-Stratification of Myocardial Injury in COVID-19: JACC Review Topic of the Week – Journal of the American College of Cardiology

Related Commentary on Twitter

Troponin increases, due to chronic myocardial injury, acute nonischemic myocardial injury or type 1 or 2 MI, are common in #COVID19 and associated with adverse outcomes. Learn more in this #JACC Review Topic of the Week: https://t.co/oOBjCCx8KJ @yadersandoval @JJheart_doc pic.twitter.com/r9HPCJ4Knd

— JACC Journals (@JACCJournals) July 8, 2020